NCT00401115 Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy Status COMPLETED Phase PHASE1
NCT00387582 Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema Status COMPLETED Phase PHASE2
NCT00370721 Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR) Status UNKNOWN Phase PHASE3
NCT00355680 Green Laser Photocoagulation Study in Proliferative Diabetic Retinopathy Status COMPLETED Phase PHASE3
NCT00347698 Intravitreal Bevacizumab vs Photocoagulation for Proliferative Diabetic Retinopathy Status WITHDRAWN Phase PHASE2/PHASE3
NCT00337298 The Effect of Amlodipine and Lisinopril on Retinal Autoregulation in Type 1 Diabetes Status COMPLETED Phase NA
NCT00336323 A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin) Status COMPLETED Phase PHASE2
NCT00295828 A Pilot Study for the Treatment of Iris Neovascularization With Macugen Status COMPLETED Phase PHASE1
NCT00248157 Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy Status TERMINATED Phase PHASE3
NCT00248131 Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy Status TERMINATED Phase PHASE3
NCT00231023 Triamcinolone Acetonide Injections to Treat Diabetic Macular Edema Status COMPLETED Phase PHASE2
NCT00211406 Treatment of Diabetic Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg) Status TERMINATED Phase PHASE1
NCT00198510 Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage Status COMPLETED Phase PHASE3
NCT00198497 Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage Status COMPLETED Phase PHASE3
NCT00198471 Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment Status COMPLETED Phase PHASE2
NCT00155454 Intravitreal Long Acting Gas in the Prevention of Early Postoperative Vitreous Hemorrhage in Diabetic Vitrectomy Status COMPLETED Phase NA